Cefdinir: an oral alternative to parenteral cephems

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Parenteral cephalosporins are standard treatments for many bacterial infections.
• Oral cephalosporins offer potential cost savings if efficacy is comparable.
• Evaluating the in vitro activity of oral cephalosporins against key pathogens is crucial.

Purpose of the Study:

• To compare the in vitro antimicrobial activity of cefdinir against other cephalosporins.
• To assess cefdinir's potency against a range of clinically relevant bacterial isolates.
• To determine if cefdinir can be considered an alternative to parenteral cephalosporins.

Main Methods:

• In vitro study design.
• Microbroth dilution methodology following National Committee for Clinical Laboratory Standards guidelines.
• Testing cefdinir, cefoxitin, cefazolin, ceftriaxone, ceftazidime, and cefepime against 243 clinical isolates.

Main Results:

• Cefdinir showed potent activity against Streptococcus pyogenes, penicillin-susceptible Streptococcus pneumoniae, methicillin-susceptible Staphylococcus aureus, and Klebsiella pneumoniae.
• Cefdinir was less potent than ceftriaxone, ceftazidime, and cefepime against Haemophilus influenzae but more potent than cefoxitin and cefazolin.
• Cefdinir exhibited slightly lower potency than ceftazidime against beta-lactamase-positive Moraxella catarrhalis.

Conclusions:

• Cefdinir exhibits significant in vitro activity against several important human pathogens.
• The data support considering cefdinir as a viable oral alternative to parenteral cephalosporins.
• Clinical use of cefdinir may be appropriate where adequate drug levels can be achieved safely.